Survey of U.S. Obstetrician‐Gynecologists' Clinical and Epidemiological Knowledge of Cryptosporidiosis in Pregnancy

Although cryptosporidiosis is frequently diagnosed in the U.S., there has been very little assessment of obstetrician–gynaecologist knowledge about this disease. In 2010, we surveyed U.S. obstetricians about the diagnosis, treatment and epidemiology of cryptosporidiosis. Data were examined through u...

Full description

Saved in:
Bibliographic Details
Published in:Zoonoses and public health 2014-08, Vol.61 (5), p.356-363
Main Authors: Domjahn, B. T, Hlavsa, M. C, Anderson, B, Schulkin, J, Leon, J, Jones, J. L
Format: Article
Language:English
Subjects:
Adult
Antiparasitic Agents - therapeutic use
Cryptosporidiosis
Cryptosporidiosis - drug therapy
Cryptosporidiosis - pathology
Cryptosporidium
Data Collection
diarrhea
drugs
Epidemiology
Female
Food and Drug Administration
Gynecology
Humans
infections in pregnancy
Logistic Models
Male
Middle Aged
multivariate analysis
notifiable disease
Obstetrics
ova
parasites
Parasitic diseases
patients
physician survey
Physicians
Pregnancy
Pregnancy Complications, Parasitic - epidemiology
regression analysis
sanitizers
surveys
Surveys and Questionnaires
United States
Zoonoses
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although cryptosporidiosis is frequently diagnosed in the U.S., there has been very little assessment of obstetrician–gynaecologist knowledge about this disease. In 2010, we surveyed U.S. obstetricians about the diagnosis, treatment and epidemiology of cryptosporidiosis. Data were examined through univariable analysis and multivariable regression models. Of 1000 obstetrician–gynaecologists surveyed, 431 (43.1%) responded. Only 44.4% of respondents correctly identified that prolonged, intermittent diarrhoea would lead them to consider cryptosporidiosis in a differential diagnosis. Routine ova and parasites (O&P) testing was incorrectly chosen to identify Cryptosporidium in stool by 30.4% of respondents. Questions about nitazoxanide, the only drug approved by the U.S. Food & Drug Administration (FDA) for treatment of cryptosporidiosis, were the most frequently missed questions. Only 9.0% of respondents correctly classified nitazoxanide as an FDA pregnancy Category B drug, and only 5.6% of respondents correctly indicated that FDA approved nitazoxanide for immunocompetent patients aged ≥1 years. Regarding prevention‐ and control‐related knowledge, only 14.1% of respondents correctly indicated that alcohol‐based hand sanitizers were not effective at inactivating Cryptosporidium spp., and
ISSN:1863-1959
1863-2378
DOI:10.1111/zph.12078